49J-60277-21613
3 vaccinations
1 coded response
10 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 073 / NJ
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
95A-15812-83283
Child or adolescent in my care · Female · 2022-06-30
2A5-10585-94815
Child or adolescent in my care · Male · 2022-06-30
Timeline
-
2021-03-17
Dose 1 — Moderna
-
2021-04-14
Dose 2 — Moderna
-
2021-04-15
Registered in v-safe
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-19
- 2021-04-28
- 2021-05-13
- 2021-05-19
- 2021-07-14
- 2021-10-13
-
2021-11-01
Dose 3 — Moderna
-
2022-05-04
Survey response — 6 months, dose 3MedDRA: Thyroid mass — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Enlarged thyroid nodules 1 week after booster.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-04
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Moderna | |
| 2 | 2021-04-14 | Moderna | |
| 3 | 2021-11-01 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-04 | Unsuccessful |
Free text
Release 11 — 6 months, dose 3
Symptoms: Enlarged thyroid nodules 1 week after booster.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Thyroid mass | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release